The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain.
about
MRI detection of VEGFR2 in vivo using a low molecular weight peptoid-(Gd)8-dendron for targetingTumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide Dendrimer (ACPPD-Gd), a T1 Magnetic Resonance (MR) Molecular Imaging AgentDesign of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkersMolecular imaging without radiopharmaceuticals?Polymeric PARACEST agents for enhancing MRI contrast sensitivity.Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agentsResponsive MRI agents for sensing metabolism in vivo.A new gadolinium-based MRI zinc sensorIn vivo imaging of molecular targets and their function in endocrinology.Optimization of gadolinium-based MRI contrast agents for high magnetic-field applications.Relaxivity of gadolinium complexes detected by atomic magnetometry.Molecular magnetic resonance contrast agents for the detection of cancer: past and present.Reporter protein-targeted probes for magnetic resonance imaging.Noninvasive MRI of β-cell function using a Zn2+-responsive contrast agent.Strategies for the preparation of bifunctional gadolinium(III) chelators.Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imagingImaging free zinc levels in vivo - what can be learned?Synthesis and Evaluation of Gd(III) -Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane AntigenComparative in vitro studies of MR imaging probes for metabotropic glutamate subtype-5 receptor targeting.Lanthanide Complexes in Molecular Magnetic Resonance Imaging and Theranostics.Synthesis and evaluation of MR probes for targeted-reporter imaging.A scale to measure MRI contrast agent sensitivity.A design strategy for small molecule-based targeted MRI contrast agents: their application for detection of atherosclerotic plaques.Synthesis and Characterization of Ligands and their Gadolinium(III) Complexes
P2860
Q24619870-D8476AC0-2AF1-4CD4-B22A-728DB43A167FQ27320124-71E1EC2B-E9A5-4196-AD1A-677B201DC954Q28283802-B4919EAA-EB7C-4DAE-8467-B2EB25A61228Q30487686-54392690-F6F4-4B8A-B248-B62114F146CAQ33371947-D6DBA68C-EC85-40EB-A632-DCAD341DFF99Q33403791-8CA6E23D-C4CF-4437-9D44-D6B512C09BF6Q33415333-D76A57E4-B356-4FF2-8FB3-2318F34A4D96Q33486687-8BD97AD5-7AF9-420E-8953-CE908A0F32E0Q33637199-AF65D8A9-8669-4C96-BA77-6218A4F332F4Q33852473-4BA3BD11-747E-4C37-9FAA-A0ADDD530695Q33854303-5468B2CD-65CE-4665-925F-0A3C17191F8FQ34823410-3FD72130-7D53-44F0-BD29-D8E48774444DQ35468836-AE10F73F-87A2-457D-A14A-350DF81B9218Q35546868-3E02F9F7-C08D-4BD7-828F-4FAC542D7574Q35777941-C18ECDE3-AF6D-4CB5-B24A-143DF4AC035BQ36372692-98B04213-8F52-49E2-B555-F376D0027AA0Q36410013-77E78169-8615-4C0B-B5B9-85736A62CDB0Q38849192-06A9F0C2-7F21-4602-83FD-C8414328ADF5Q39113752-1DDDE4E0-3647-491A-8C9F-5F3CD92605A3Q39282793-962E7AF5-26E5-4074-8E71-BDBB7B87E914Q42367441-AFE2431C-073A-4499-B7E2-F8782318335DQ43496696-60610194-1F8C-492E-9300-BDD6E0EA935FQ51057792-DFBF52AD-E15E-47BD-8325-BAB9E1090A2CQ57340454-D11A09D7-EB16-4530-AC77-76F64A3948C0
P2860
The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The detection limit of a Gd3+- ...... eted to a protein microdomain.
@ast
The detection limit of a Gd3+- ...... eted to a protein microdomain.
@en
type
label
The detection limit of a Gd3+- ...... eted to a protein microdomain.
@ast
The detection limit of a Gd3+- ...... eted to a protein microdomain.
@en
prefLabel
The detection limit of a Gd3+- ...... eted to a protein microdomain.
@ast
The detection limit of a Gd3+- ...... eted to a protein microdomain.
@en
P2093
P2860
P1476
The detection limit of a Gd3+- ...... eted to a protein microdomain.
@en
P2093
A Dean Sherry
Aminta Castillo-Muzquiz
Angelo Josue M Lubag
Kenjiro Hanaoka
Thomas Kodadek
P2860
P304
P356
10.1016/J.MRI.2007.11.002
P577
2008-01-30T00:00:00Z